CEO attending BIO International, Boston

John Ridden, Blueberry CEO will be attending BIO International convention in Boston, 4th-7th June. 2018 is the 25th year for the BIO Convention, and attracts more than 16,000 biotechnology and pharma leaders who come [...]

2018-06-06T10:59:40+00:00 May 29th, 2018|

CEO presents to Chinese investors and companies

John Ridden, CEO of Blueberry Therapeutics, recently presented at the UK-China Life Science Event run by the DIT (Department for International Trade). The event was hosted by Lancaster University and is an opportunity for [...]

2018-02-13T12:31:31+00:00 November 6th, 2017|

CEO John Ridden presents at Biofocus 2017

Blueberry Therapeutics CEO John Ridden presented at the Biofocus 2017 event at the Centre for Life in Newcastle upon Tyne as part of the Industry Showcase session. The Biofocus event is an annual event bringing [...]

2017-06-30T13:54:43+00:00 June 29th, 2017|

David Cook presents at ELRIG

CSO David Cook presented at the recent ELRIG (European Laboratory Research & Innovation Group) held at Alderley Park. David presented as part of a diverse evening of seminars on the topic “Novel Approaches to Meeting [...]

2017-05-31T13:17:07+00:00 May 18th, 2017|

Blueberry in the news again!

Blueberry's CEO John Ridden was interviewed by Times writer Michael Cape. John and Michael spoke about how Blueberry benefitted from AstraZeneca's move to Cambridge, which led to husband and wife team David and Julie [...]

2018-02-13T12:31:32+00:00 March 16th, 2017|

Blueberry CSO presents at Superbugs & Superdrugs conference

CSO David Cook presents at the “Superbugs & Supderdrugs” conference held in Iselin, USA. The conference brought together experts in anti-microbial drug resistance from Government, Pharma and Biotech. David gave a presentation on “Targeting Mechanisms [...]

2017-02-16T10:30:04+00:00 November 14th, 2016|